EZETIMIBE ALTER 10 mg, tablet 90 tablets
Active ingredients: Ezetimibe
Commercialized according to BDPMDispensing in France: Prescription only
Tablet90 tabletsorale
No current ANSM shortage notice is included
Package details
Original BDPM fields are shown in French.
- Official name
- EZETIMIBE ALTER 10 mg, comprimé
- Pharmaceutical form
- comprimé
- Route of administration
- orale
- Presentation description
- plaquette(s) PVC polychlortrifluoroéthylène aluminium de 90 comprimé(s)
- Marketing authorisation holder
- LABORATOIRES ALTER
- Reimbursement according to BDPM
- 65%
- Approval for use in healthcare institutions
- non
- Commercialization declaration date
- 27 Jun 2024
- Prescription and dispensing conditions
- Prescription only
- List I: prescription-only medicine
- Enhanced ANSM monitoring
- No
BDPM identifiers
CIS
65303899CIP73007398CIP133400930073988Composition in BDPM
| Component | Amount per unit | Source type |
|---|---|---|
| ÉZÉTIMIBEcomprimé | 10 mg · un comprimé | SA |
Information is based on BDPM data and is for reference only. Consult a doctor before use.
Other packages of this medicine
The same medicine in another pack size, according to BDPM.
Similar medicines
Similar medicines are listed using the official BDPM catalog. Availability must be checked separately. Consult a doctor or pharmacist before switching medicines.
The current BDPM data does not list similar medicines for this product.